THOMAS G. WIGGANS - 01 Dec 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC.

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Dec 2022
Net transactions value
+$39,375
Form type
4
Filing time
05 Dec 2022, 15:21:21 UTC
Previous filing
14 Oct 2022
Next filing
07 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRDS Common Stock Purchase $26,000 +25,000 $1.04 25,000 01 Dec 2022 Direct F1, F2
transaction PRDS Common Stock Purchase $13,375 +12,500 +50% $1.07 37,500 02 Dec 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $0.96025 to $1.05.
F2 The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
F3 The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $1.02 to $1.12.